151 related articles for article (PubMed ID: 32854760)
21. P110β Inhibition Reduces Histone H3K4 Di-Methylation in Prostate Cancer.
Pang J; Yang YW; Huang Y; Yang J; Zhang H; Chen R; Dong L; Huang Y; Wang D; Liu J; Li B
Prostate; 2017 Feb; 77(3):299-308. PubMed ID: 27800642
[TBL] [Abstract][Full Text] [Related]
22. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
[TBL] [Abstract][Full Text] [Related]
23. Regulation of miRNA Biogenesis and Histone Modification by K63-Polyubiquitinated DDX17 Controls Cancer Stem-like Features.
Kao SH; Cheng WC; Wang YT; Wu HT; Yeh HY; Chen YJ; Tsai MH; Wu KJ
Cancer Res; 2019 May; 79(10):2549-2563. PubMed ID: 30877109
[TBL] [Abstract][Full Text] [Related]
24. Antrodia cinnamomea Enhances Chemo-Sensitivity of 5-FU and Suppresses Colon Tumorigenesis and Cancer Stemness via Up-Regulation of Tumor Suppressor miR-142-3p.
Huang YJ; Yadav VK; Srivastava P; Wu AT; Huynh TT; Wei PL; Huang CF; Huang TH
Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31349708
[TBL] [Abstract][Full Text] [Related]
25. HDAC and MAPK/ERK Inhibitors Cooperate To Reduce Viability and Stemness in Medulloblastoma.
da Cunha Jaeger M; Ghisleni EC; Cardoso PS; Siniglaglia M; Falcon T; Brunetto AT; Brunetto AL; de Farias CB; Taylor MD; Nör C; Ramaswamy V; Roesler R
J Mol Neurosci; 2020 Jun; 70(6):981-992. PubMed ID: 32056089
[TBL] [Abstract][Full Text] [Related]
26. S100B Mediates Stemness of Ovarian Cancer Stem-Like Cells Through Inhibiting p53.
Yang T; Cheng J; Yang Y; Qi W; Zhao Y; Long H; Xie R; Zhu B
Stem Cells; 2017 Feb; 35(2):325-336. PubMed ID: 27501952
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of mitochondrial cyclooxygenase-2 inhibits the stemness of nasopharyngeal carcinoma by decreasing the activity of dynamin-related protein 1.
Zhou TJ; Zhang SL; He CY; Zhuang QY; Han PY; Jiang SW; Yao H; Huang YJ; Ling WH; Lin YC; Lin ZN
Theranostics; 2017; 7(5):1389-1406. PubMed ID: 28435473
[TBL] [Abstract][Full Text] [Related]
28. Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells.
Aztopal N; Erkisa M; Erturk E; Ulukaya E; Tokullugil AH; Ari F
Chem Biol Interact; 2018 Jan; 280():51-58. PubMed ID: 29225137
[TBL] [Abstract][Full Text] [Related]
29. Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis.
Sun L; Huang C; Zhu M; Guo S; Gao Q; Wang Q; Chen B; Li R; Zhao Y; Wang M; Chen Z; Shen B; Zhu W
Theranostics; 2020; 10(26):11950-11962. PubMed ID: 33204322
[No Abstract] [Full Text] [Related]
30. Knocking down LSD1 inhibits the stemness features of colorectal cancer stem cells.
Chen J; Zhao J; Ding J; Wang Z; Du J; Wu C
Braz J Med Biol Res; 2020; 53(7):e9230. PubMed ID: 32520208
[TBL] [Abstract][Full Text] [Related]
31. Scutellariabarbata D. Don extraction selectively targets stemness-prone NSCLC cells by attenuating SOX2/SMO/GLI1 network loop.
Chen WW; Gong KK; Yang LJ; Dai JJ; Zhang Q; Wang F; Li XL; Xi SC; Du J
J Ethnopharmacol; 2021 Jan; 265():113295. PubMed ID: 32841701
[TBL] [Abstract][Full Text] [Related]
32. Targeted inhibition of KDM6 histone demethylases eradicates tumor-initiating cells via enhancer reprogramming in colorectal cancer.
Zhang J; Ying Y; Li M; Wang M; Huang X; Jia M; Zeng J; Ma C; Zhang Y; Li C; Wang X; Shu XS
Theranostics; 2020; 10(22):10016-10030. PubMed ID: 32929331
[TBL] [Abstract][Full Text] [Related]
33. STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway.
Xu S; Yue Y; Zhang S; Zhou C; Cheng X; Xie X; Wang X; Lu W
J Exp Clin Cancer Res; 2018 Dec; 37(1):305. PubMed ID: 30518424
[TBL] [Abstract][Full Text] [Related]
34. Eckol suppresses maintenance of stemness and malignancies in glioma stem-like cells.
Hyun KH; Yoon CH; Kim RK; Lim EJ; An S; Park MJ; Hyun JW; Suh Y; Kim MJ; Lee SJ
Toxicol Appl Pharmacol; 2011 Jul; 254(1):32-40. PubMed ID: 21514314
[TBL] [Abstract][Full Text] [Related]
35. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
[TBL] [Abstract][Full Text] [Related]
36. Somatostatin signaling via SSTR1 contributes to the quiescence of colon cancer stem cells.
Modarai SR; Opdenaker LM; Viswanathan V; Fields JZ; Boman BM
BMC Cancer; 2016 Dec; 16(1):941. PubMed ID: 27927191
[TBL] [Abstract][Full Text] [Related]
37. Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin.
Wang Q; Chen X; Jiang Y; Liu S; Liu H; Sun X; Zhang H; Liu Z; Tao Y; Li C; Hu Y; Liu D; Ye D; Liu Y; Wang M; Zhang X
J Mol Cell Biol; 2020 Feb; 12(2):125-137. PubMed ID: 31065671
[TBL] [Abstract][Full Text] [Related]
38. Histone deacetylases inhibitor MS-275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway.
Ma S; Liu T; Xu L; Wang Y; Zhou J; Huang T; Li P; Liu H; Zhang Y; Zhou X; Cui Y; Zang X; Wang Y; Guan F
J Cell Physiol; 2019 Dec; 234(12):22400-22410. PubMed ID: 31120582
[TBL] [Abstract][Full Text] [Related]
39. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
[TBL] [Abstract][Full Text] [Related]
40. SIRT6 Suppresses Cancer Stem-like Capacity in Tumors with PI3K Activation Independently of Its Deacetylase Activity.
Ioris RM; Galié M; Ramadori G; Anderson JG; Charollais A; Konstantinidou G; Brenachot X; Aras E; Goga A; Ceglia N; Sebastián C; Martinvalet D; Mostoslavsky R; Baldi P; Coppari R
Cell Rep; 2017 Feb; 18(8):1858-1868. PubMed ID: 28228253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]